Skip to main content
Log in

Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

About 70% of eye drops contain benzalkonium chloride (BAK) to maintain sterility. BAK is an effective preservative but it can cause irritation and toxicity. We propose to mitigate ocular toxicity without compromising sterility by incorporating a filter into an eye drop bottle to selectively remove BAK during the process of drop instillation.

Methods

The filter is a packed bed of particles made from poly(2-hydroxyethyl methacrylate) (pHEMA), which is a common ophthalmic material. We showed that pHEMA particle prepared by using ethoxylated trimethylolpropane triacrylate as crosslinker can be incorporated into a modified eyedrop bottle tip to selectively remove the preservative as the formulation is squeezed out of the bottle. Hydraulic permeability of the plug is measured to determine the resistance to eye drop squeezing, and % removal of BAK and drugs are determined.

Results

The modified tip has a hydraulic permeability of about 2 Darcy, which allows eyedrops formulations to flow through without excessive resistance. The tip is designed such that the patients can create an eyedrop of solution of 1–10 cP viscosity in 4 s with a nominal pressure. During this short contact time, the packed particles removed nearly 100% of benzalkonium chloride (BAK) from a 15 mL, 0.012% BAK solution but have only minimal impact on the concentration of contained active components.

Conclusion

Our novel design can eliminate the preservative induced toxicity from eye drops thereby impacting hundreds of millions of patients with chronic ophthalmic diseases like glaucoma and dry eyes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

∆P :

Pressure drop across the bed

A :

Cross-sectional area of the bed

BAK:

Benzalkonium chloride

CMC:

Carboxymethyl cellulose

Da:

Darcy (=0.9869233 (μm)2)

H :

Length of the packed bed

HEMA:

2-hydroxyethyl methacrylate

k :

Hydraulic permeability of the packed bed

pHEMA:

Poly (hydroxyethyl methacrylate)

SR454HP:

Ethoxylated (3) trimethylolpropane triacrylate

SR9035:

Ethoxylated (15) trimethylolpropane triacrylate

UVB:

Ultraviolet B (280–315 nm)

μ :

Fluid viscosity

References

  1. Wilson LA. To preserve or not to preserve, is that the question? Br J Ophthalmol. 1996;80:583–4.

    Article  CAS  Google Scholar 

  2. Kim MS, Choi CY, Kim JM, Chung H, Woo H. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Br J Ophthalmol. 2008;92:1518–21.

    Article  CAS  Google Scholar 

  3. Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312–34.

    Article  CAS  Google Scholar 

  4. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008;86:716–26.

    Article  Google Scholar 

  5. Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol. 2007;17:341–9.

    Article  CAS  Google Scholar 

  6. Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma. 2003;12:486–90.

    Article  Google Scholar 

  7. Baudouin C, de Lunardo C. Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol. 1998;82:39–42.

    Article  CAS  Google Scholar 

  8. Rolando M, Brezzo V, Giordano G, Campagna P, Burlando S, Calabria G. The effect of different benzalkonium chloride concentrations on human normal ocular surface. In: Van Bijsterveld O, Lemp M, Spinelli D, editors. The Lacrimal System. Amsterdam, Berkely, Milano: Kugler and Ghedini Publications; 1991. p. 87–91.

  9. Nuzzi R, Finazzo C, Vercelli A, Cracco C. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1995;233:154–62.

    Article  CAS  Google Scholar 

  10. Cogger JJ, Haffner DS. Multiple precision dose, preservative-free medication delivery system. US6254579B1, 2001.

  11. Haffner DS, Myall PA, Evans B. Twist housing apparatus for instilling a medication into an eye. US6533764B1, 2003.

  12. Boyles JV, Kent JS. Storage and delivery of multi-dose, preservative-free pharmaceuticals. US6450994B1, 2002.

  13. Cogger JJ. Housing apparatus with rear activated return button for instilling a medication into an eye. US6524287B1, 2003.

  14. Malet F, Karsenti D, Pouliquen P. Preservative-free ocular hydrating agents in symptomatic contact lens wearers: saline versus PVP solution. Eye Contact Lens. 2003;29:38–43.

    Article  Google Scholar 

  15. Teping C, Wiedemann B. The COMOD system. A preservative-free multidose container for eyedrops. Klin Monatsbl Augenheilkd. 1994;205:210–7.

    Article  CAS  Google Scholar 

  16. Hsu K-H, Chauhan A. Rapid and selective removal of preservative from ophthalmic formulations during eye drop instillation. Eur J Pharm Biopharm. 2015;97:30–8.

    Article  CAS  Google Scholar 

  17. Kim J, Chauhan A. Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels. Int J Pharm. 2008;353:205–22.

    CAS  PubMed  Google Scholar 

  18. Hsu K-H, Carbia BE, Plummer C, Chauhan A. Dual Drug Delivery from Vitamin E loaded contact lenses for glaucoma therapy. Eur J Pharm Biopharm. 2015;94:312–21.

    Article  CAS  Google Scholar 

  19. Horak D, Chaykivskyy O. Poly(2-Hydroxyethyl Methacrylate-coN,O-Dimethacryloylhydroxylamine) particles by dispersion polymerization. J Polym Sci A Polym Chem. 2002;40:1625–32.

    Article  CAS  Google Scholar 

  20. Takahashi K, Miyamori S, Uyama H, Kobayashi S. Preparation of micron-size monodisperse poly(2-hydroxyethyl methacrylate) particles by dispersion polymerization. J Polym Sci A Polym Chem. 1996;34:175–82.

    Article  CAS  Google Scholar 

  21. Horak D, Svec F, Kalal J, et al. Hydrogels in endovascular embolization. I. Spherical particles of poly(2-hydroxyethyl methacrylate) and their medicobiological properties. Biomaterials. 1986;7:188–92.

    Article  CAS  Google Scholar 

  22. I. Brenntag Specialties. AQUALON® Sodium Carboxymethylcellulose Physical and Chemical Properties. In http://www.brenntagspecialties.com/en/downloads/Products/Multi_Market_Principals/Aqualon/Aqualon_CMC_Booklet.pdf, 1999.

Download references

ACKNOWLEDGMENTS AND DISCLOSURES

The work reported here is a part of a pending utility patent which is licensed to TearClear.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anuj Chauhan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hsu, KH., Gupta, K., Nayaka, H. et al. Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations. Pharm Res 34, 2862–2872 (2017). https://doi.org/10.1007/s11095-017-2270-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-017-2270-8

Key Words

Navigation